BSE filing, NSE: KOVAI. Summary written from the filing by ALFA Finder's alert engine.
Kovai Medical Center and Hospital Ltd: key numbers
- Share price
- ₹5,898.95
- Market cap
- ₹6,455 Cr
- Revenue (annual)
- ₹1,586 Cr
- Net profit (annual)
- ₹244.5 Cr
- P/E (TTM)
- 25.6×Sector 51.1×
- Promoter holding
- 56.53%+0.01% QoQ
- FII holding
- 1.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kovai Medical Center and Hospital Ltd
All →Kovai Medical Center and Hospital Other Announcement
Kovai Medical Center & Hospital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This is a routine periodic regulatory disclosure with no new transaction.
Kovai Medical Center and Hospital Promoter Buying: ₹0.19 Cr
Promoter Pavai Property Developers acquired 316 shares of Kovai Medical Center via open market purchase for ₹0.19 Crore. This increases their holding slightly.
- Value
- ₹0.19 Cr
Kovai Medical Center and Hospital Promoter Buying: ₹0.31 Cr
Promoter entity Pavai Property Developers Private Limited purchased 500 equity shares of Kovai Medical Center & Hospital Ltd via market acquisition.
- Value
- ₹0.31 Cr
Kovai Medical Center and Hospital Annual General Meeting
Kovai Medical Center shareholders approved Dr. Arun N Palaniswami's re-designation as Joint Managing Director via postal ballot. The resolution passed with 96% assent in September 2026.
Kovai Medical Center and Hospital Annual General Meeting
Kovai Medical Center and Hospital Limited has issued a Postal Ballot Notice seeking shareholder approval for the re-designation of Dr. Arun N Palaniswami as Joint Managing Director.
Kovai Medical Center and Hospital Promoter Buying (Off-Market)
Promoter Palaniswami N acquired 12,59,725 shares (11.51% stake) of Kovai Medical Center via inheritance. His total holding increased from 0.09% to 11.60% post-transaction.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.